J Roberts1, R Ronn2, N Tallon1, H Holzer3. 1. Pacific Centre for Reproductive Medicine, Burnaby, BC; 2. Department of Obstetrics and Gynecology, Queen's University, Kingston, ON; 3. McGill University Health Centre, Reproductive Centre, and Department of Obstetrics and Gynecology, McGill University, Montreal, QC.
Abstract
BACKGROUND: Advancements in the treatments for cancer and autoimmune and other hematologic conditions continue to improve survival and cure rates. Despite those changes, various gonadotoxic agents and other treatments can still compromise the future fertility of many women. Progress in medical and surgical reproductive technologies has helped to offset the reproductive consequences of the use of gonadotoxic therapies, and allows for future fertility and normal pregnancy. METHODS: A review of the literature was performed to outline the pathophysiology of gonadotoxicity from various treatments. The success of fertility preservation, fertility sparing, and cryopreservation options are reviewed. Barriers and facilitators to referral and oncofertility treatment in Canada are also outlined. RESULTS: According to the quality of the evidence, recommendations are made for fertility assessment, patient referral, cryopreservation, and other assisted reproductive technologies. CONCLUSIONS: To ensure ongoing fertility in women undergoing gonadotoxic treatments, assisted reproductive technologies can be combined with a multidisciplinary approach to patient assessment and referral.
BACKGROUND: Advancements in the treatments for cancer and autoimmune and other hematologic conditions continue to improve survival and cure rates. Despite those changes, various gonadotoxic agents and other treatments can still compromise the future fertility of many women. Progress in medical and surgical reproductive technologies has helped to offset the reproductive consequences of the use of gonadotoxic therapies, and allows for future fertility and normal pregnancy. METHODS: A review of the literature was performed to outline the pathophysiology of gonadotoxicity from various treatments. The success of fertility preservation, fertility sparing, and cryopreservation options are reviewed. Barriers and facilitators to referral and oncofertility treatment in Canada are also outlined. RESULTS: According to the quality of the evidence, recommendations are made for fertility assessment, patient referral, cryopreservation, and other assisted reproductive technologies. CONCLUSIONS: To ensure ongoing fertility in women undergoing gonadotoxic treatments, assisted reproductive technologies can be combined with a multidisciplinary approach to patient assessment and referral.
Entities:
Keywords:
Oncofertility; adolescents; cryopreservation; fertility preservation; gonadotoxicity; young adults
Authors: Mark F H Brougham; Patricia M Crofton; Emma J Johnson; Nancy Evans; Richard A Anderson; W Hamish B Wallace Journal: J Clin Endocrinol Metab Date: 2012-04-03 Impact factor: 5.958
Authors: Michael Helewa; Pierre Lévesque; Diane Provencher; Robert H Lea; Vera Rosolowich; Heather M Shapiro Journal: J Obstet Gynaecol Can Date: 2002-02
Authors: Gwendolyn P Quinn; Susan T Vadaparampil; Clement K Gwede; Cheryl Miree; Lindsey M King; Heather B Clayton; Crystal Wilson; Pamela Munster Journal: J Cancer Surviv Date: 2007-06 Impact factor: 4.062
Authors: Gulzhanat Aimagambetova; Sanja Terzic; Antonio Simone Laganà; Gauri Bapayeva; Philip la Fleur; Milan Terzic Journal: J Clin Med Date: 2021-12-30 Impact factor: 4.241
Authors: L Turkgeldi; A Cutner; E Turkgeldi; A Al Chami; A Cassoni; N Macdonald; T Mould; A Nichol; A Olaitan; E Saridogan Journal: Facts Views Vis Obgyn Date: 2019-09